1 June 2026CompletedHealthcare
Servier Pharmaceuticals LLC and Les Laboratoires Servier to acquire Edgewise Therapeutics, Inc.
Servier Pharmaceuticals LLC and Les Laboratoires Servier and Edgewise Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- Servier Pharmaceuticals LLC and Les Laboratoires Servier
- Target
- Edgewise Therapeutics, Inc.
- Deal value
- USD 2,650,000,000
- Deal type
- strategic acquisition
